Trader J's Inner Circle Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Trader J's Inner Circle

NVDA 180.94

-1.5%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: wwmd who wrote (10992)	3/11/1999 2:01:00 AM
From: Jon K.	Read Replies (1) of 56535

wwmd, IMCL, looks like phase III will take about 3months (12 weeks) From IMCL company's web site: >>>a randomized, double blind, phase III study in patients with locally recurrent or metastatic disease. Patients will receive standard monthly cisplatin in combination with either placebo or C225. This cooperative group study is planned to begin enrollment in early 1999. a randomized phase III study in patients with locally advanced disease. Patients will be treated with radiation therapy alone or radiation therapy plus 12 weekly infusions of C225. Patients will be stratified for either standard or hyperfractionated radiation therapy. This multi-center, multi-national study is planned to begin enrollment in January 1999. <<<

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next